Clinical Trial Update: A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating brivaracetam for increased seizure activity in an epilepsy monitoring unit; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Biopharma S.P.R.L. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2019-05-28